These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6691680)

  • 21. Circulatory effects of noradrenaline and adrenaline before and after labetalol.
    Richards DA; Prichard BN; Hernández R
    Br J Clin Pharmacol; 1979 Apr; 7(4):371-8. PubMed ID: 444356
    [No Abstract]   [Full Text] [Related]  

  • 22. The response of plasma catecholamines to intravenous labetalol: a comparison with sodium nitroprusside.
    Lin MS; McNay JL; Shepherd AM; Keeton TK
    Clin Pharmacol Ther; 1983 Oct; 34(4):466-73. PubMed ID: 6617068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenaline induced dysrhythmias: comparison of the antidysrhythmic effect of labetalol with propranolol during normocarbia and hypercarbia in halothane anaesthetized cats.
    Forbes R; Clanachan AS; Moonie GT
    Proc West Pharmacol Soc; 1980; 23():37-40. PubMed ID: 6773062
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of labetalol and propranolol on responses to adrenaline infusion in healthy volunteers.
    Doshi BS; Kulkarni RD; Dattani KK; Anand MP
    Int J Clin Pharmacol Res; 1984; 4(1):29-33. PubMed ID: 6469431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of labetalol on the excretion of catecholamines and their metabolites in primary hypertension].
    Wocial B; Sznajderman M; Brym E; Cybulska I; Czerniewska E
    Pol Tyg Lek; 1981 Aug; 36(35):1337-9. PubMed ID: 7329848
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of labetalol and propranolol on human cutaneous vasoconstrictor response to adrenaline.
    Doshi BS; Kulkarni RD; Dattani KK; Anand MP
    Int J Clin Pharmacol Res; 1984; 4(1):25-8. PubMed ID: 6469430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic and haemodynamic effects of increased circulating adrenaline in man. Effect of labetalol, an alpha and beta blocker.
    Struthers AD; Whitesmith R; Reid JL
    Br Heart J; 1983 Sep; 50(3):277-81. PubMed ID: 6615664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of predictive values.
    McCarthy D
    N Engl J Med; 1980 Jun; 302(26):1479-80. PubMed ID: 7374716
    [No Abstract]   [Full Text] [Related]  

  • 29. Labetalol in hypertension.
    Raftery EB
    Lancet; 1977 Jun; 1(8024):1269. PubMed ID: 68378
    [No Abstract]   [Full Text] [Related]  

  • 30. [Plasma and urinary metanephrine in essential hypertension. Determination of metanephrine by radioimmunoassay].
    Shigetomi S; Ueno S; Hashimoto S; Satoh M; Satoh K; Kohno H; Tosaki H; Fukuchi S; Iinuma K
    Nihon Jinzo Gakkai Shi; 1985 Jun; 27(6):833-8. PubMed ID: 4079115
    [No Abstract]   [Full Text] [Related]  

  • 31. A method for monitoring drug effects on male sexual response: the effect of single dose labetalol.
    Riley AJ; Riley EJ; Davies HJ
    Br J Clin Pharmacol; 1982 Nov; 14(5):695-700. PubMed ID: 7138749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacology of labetalol.
    Richards DA; Prichard BN
    Br J Clin Pharmacol; 1979; 8(Suppl 2):89S-93S. PubMed ID: 43165
    [No Abstract]   [Full Text] [Related]  

  • 33. Biochemical evidence for the dual action of labetalol on alpha- and beta-adrenoceptors.
    Aggerbeck M; Guellaen G; Hanoune J
    Br J Pharmacol; 1978 Apr; 62(4):543-8. PubMed ID: 26446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modification of morphine analgesia by labetalol.
    Khanna NK; Dadhich AP; Vyas DS
    Indian J Exp Biol; 1978 Oct; 16(10):1091-2. PubMed ID: 750393
    [No Abstract]   [Full Text] [Related]  

  • 35. Labetalol and lipids.
    McGonigle RJ; Williams L; Murphy MJ; Parsons V
    Lancet; 1981 Jan; 1(8212):163. PubMed ID: 6109848
    [No Abstract]   [Full Text] [Related]  

  • 36. Rate of onset of hypotensive response with oral labetalol [proceedings].
    Breckenridge AM; Macnee CM; Orme NL; Richards DA; Sterlin MJ
    Br J Clin Pharmacol; 1977 Jun; 4(3):388P. PubMed ID: 901712
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of labetalol on adrenergic transmission in the rat anococcygeus muscle [proceedings].
    Doggrell SA; Paton DM
    Br J Pharmacol; 1978 Mar; 62(3):380P. PubMed ID: 205294
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hemodynamic study of a new injectable anti-hypertensive: labetalol].
    Clementy J; Dallocchio M
    Nouv Presse Med; 1978 Dec; 7(43):3934. PubMed ID: 733550
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.
    Elliott HL; McLean K; Meredith PA; Sumner DJ; Reid JL
    Br J Clin Pharmacol; 1984 May; 17(5):565-72. PubMed ID: 6145440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Some further evidence for partial agonist activity of labetalol.
    Riley AJ
    Br J Clin Pharmacol; 1980 May; 9(5):517-8. PubMed ID: 6104978
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.